Turn Therapeutics Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TTRX research report →
About the company
Turn Therapeutics Inc. , officially known as Global Health Solutions, Inc. , is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes.
- CEO
- Bradley E. Burnam
- IPO
- 2025
- Employees
- 2
- HQ
- Westlake Village, CA, US
Price Chart
- Market Cap
- $212.09M
- P/E
- -39.19
- P/S
- 0.00
- P/B
- 34.31
- EV/EBITDA
- -54.52
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -116.83%
- ROIC
- -49.55%
- Revenue
- $0 · 0.00%
- Net Income
- $-3,194,080 · -80.62%
- EPS
- $-0.23 · -76.92%
- Op Income
- $-5,858,648
- FCF YoY
- -85.92%
- 52W High
- $26.50
- 52W Low
- $2.57
- 50D MA
- $5.09
- 200D MA
- $4.27
- Beta
- 2.10
- Avg Volume
- 43.11K
Get TickerSpark's AI analysis on TTRX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our TTRX coverage
Recent articles, reports, and earnings notes.
No research on TTRX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TTRX report →Similar companies
Peers in the same neighborhood.